BioAtla, Inc. 8-K

What Happened

• BioAtla, Inc. announced its financial results for the fourth quarter and fiscal year ended December 31, 2025 via a press release dated March 31, 2026. The company filed a Form 8‑K reporting these results under Item 2.02 and also disclosed an updated corporate presentation under Item 7.01. The press release is attached as Exhibit 99.1 and the corporate presentation as Exhibit 99.2 to the filing. The Form 8‑K was signed by CFO Christian Vasquez.

Key Details

• Filing date: March 31, 2026 (Form 8‑K Items 2.02 and 7.01).
• Results cover: Fourth quarter and fiscal year ended December 31, 2025.
• Exhibits: Press release (Exhibit 99.1) and updated Corporate Presentation (Exhibit 99.2).
• Technical disclosure: Cover page Inline XBRL tags included (Exhibit 104).

Why It Matters

• The press release provides investors the company’s latest reported quarterly and full‑year financial information—key for assessing earnings, revenue trends, cash position and progress against milestones.
• The updated corporate presentation is the company’s current investor-facing material and may be used in meetings with analysts, investors and potential partners; reviewing it alongside the press release gives a clearer picture of BioAtla’s messaging and performance.
• Retail investors should review the attached press release and presentation (Exhibits 99.1 and 99.2) for the specific financial metrics and any management commentary before making investment decisions.